Contrarian Corpus
short seller full deck initial thesis
2024-01-17 · 123 pages

MSCI Inc. MSCI

Spruce Point rates MSCI a Strong Sell: accounting red flags, nepotism-like M&A, eroding ESG lead and a CAO resignation expose 55-65% ($190-$244) downside to MSCI's premium multiple.

N 5 Narrative
V 3 Visual
C 3 Craft
Unlock to download PDF Spruce Point research ↗

Thesis

Spruce Point issues a 'Strong Sell' on MSCI Inc. ($48bn S&P 500 index/analytics/ESG provider), arguing its 17x/29x 2024E revenue/EBITDA multiple cannot survive forensic scrutiny. Core Index (58% of revenue) faces BlackRock self-indexing and Qontigo/Nasdaq competition; Analytics is commoditized; ESG/Climate growth is stalling as Bloomberg and Moody's attack. Management has doubled down with nepotism-like deals benefiting Morgan Stanley alums — Burgiss at 10x/68x sales/EBITDA, Real Capital Analytics at 13x/48x — while shifting focus to 'Adjusted' EPS inflated by $2.3bn of buybacks and capitalized software. The CFO, Chief Accounting Officer and Global Controller have all departed; Director Catherine Kinney sat on SolarWinds' board when the SEC charged fraud; PwC's audit partner is an industrial-products specialist. Sum-of-parts yields $178-$244/share versus $542, implying 55-65% downside.

SCQA

Situation

MSCI Inc. is a $48bn S&P 500 provider of global indexes, analytics, and ESG/climate ratings whose benchmarks guide trillions of dollars in asset allocation and whose premium 17x/29x 2024E multiple assumes durable compounder status.

Complication

Forensic review reveals eroding competitive position (BlackRock self-indexing, Bloomberg ESG, commoditized Analytics), nepotism-like M&A at inflated multiples, aggressive Adj. EPS accounting, departing CFO/CAO/Controller, and a director tied to SolarWinds' SEC fraud case.

Resolution

Underweight or short MSCI and pair with long ESG Overachievers ETF; demand a new financial-services audit engagement partner, replacement of Director Kinney, permanent CAO/Controller, and disclosure of organic growth and cash-flow targets.

Reward

Sum-of-parts valuation yields $178-$244/share versus $542 market price, implying 55-65% downside as MSCI's extreme premium to its financial-services peer group compresses toward sector norms.

The three reasons

  1. 1

    Nepotism-like $1bn M&A at 10-13x sales (Burgiss, RCA) benefits Morgan Stanley alums while clients decline.

  2. 2

    Adj. EPS inflated by $2.3bn of buybacks while CFO and Chief Accounting Officer both recently resigned.

  3. 3

    Sum-of-parts yields $178-$244/share, 55-65% below $542 as ESG growth stalls and BlackRock self-indexes.

Primary demands

  • Underweight or short MSCI shares and pair with a long position in the ESG Overachievers ETF
  • Replace the audit engagement partner with a qualified financial-services specialist
  • Name a permanent Chief Accounting Officer and Global Controller
  • Provide organic revenue guidance and cash-flow targets rather than opaque Adj. EPS metrics
  • Remove Director Catherine Kinney given her role at SolarWinds during SEC fraud period
  • Separate the Chairman and CEO roles held by Henry Fernandez

KPIs cited

Downside target
Fair value $190-$244/share, 55-65% below $542 market price
EV/2024E EBITDA
MSCI 28.3x vs 18.2x financial-services peer average (highest in group)
EV/2024E Revenue
MSCI 17.0x vs 8.0x peer average — top of chart
Net Debt/EBITDA
3.0x pro forma — decade high, up from 0.7x in 2014
Client count
Fell from 6,600 (Q4'22) to 6,500 (Q3'23) — first decline in years
Burgiss acquisition multiple
Paid ~10x sales and 68x EBITDA in 2023
Real Capital Analytics acquisition multiple
$949M at ~13x sales and 48x EBITDA in 2021; client count marked down 2,000 to 1,600
Adj. EPS overstatement
MSCI figure 13-28% above Spruce Point's adjusted calculation in 2020-22
Dividend growth rate
Most recent increase 10.4% vs 27.9% long-term average since 2014 — lowest ever
Share repurchases
$2.3bn spent in past three years modifying capital structure to boost Adj. EPS
ESG & Climate revenue
Run-rate grew from $138M to $297M since 2020 but growth now decelerating
Sell-side consensus upside
$556 average price target = only 2.6% implied upside

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns. Orange cells are present in this deck; neutral cells are not.

Precedents cited

  • Xylem short call (Aug 2023) — 17% decline, CFO and CEO departed
  • Generac short call (Jun 2022) — 60% decline, COO resigned, SEC subpoena
  • A.O. Smith short call (May 2019) — 30% decline, China head fired
  • SolarWinds SEC fraud case (Oct 2023) — internal control failures

Composition what's on the 123 slides

Visual + textual elements counted across every slide in this deck. Hover a box for what that element is; click to see every slide in the corpus that uses it.

Slide gallery ·

All 123
No slide inventory yet

Pass-2 extraction may still be in progress for this deck.

Notes

Classic Spruce Point forensic short deck: 123-page institutional research note with SCQA-like red-alert summary on p.6, enumerated 'Red Flags' checklist on p.13, sum-of-parts finale on p.122, proprietary 'F' ESG rating on p.123. Rhetorical device: uses MSCI's own ESG-rating framework to assign MSCI itself an 'F'. Quote-contradiction pattern: MSCI rewording '"Unique Track Record"' to '"Long Track Record"' in ESG 10-K. Short position disclosed in boilerplate but no specific % stake given (typical short-seller practice). Track record framing via prior Xylem/Generac/A.O. Smith calls on p.4 is a recurring Spruce Point opener worth cataloging as a genre pattern.